 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
1 to 18 of 18 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
Geschwind D. on PAPER: Galpern WR. et al., 2006, Recommendation Only. 27 Feb 2006.
|
 |
 |
 |
 |
 |
Geschwind D. on PAPER: Kukull WA. et al., 2006, Recommendation Only. 27 Feb 2006.
|
 |
 |
 |
 |
 |
Geschwind D. on PAPER: Jia Z. et al., 2005, This paper addresses an important area that is largely unexplored in disease. For example, one... 13 Feb 2006.
|
 |
 |
 |
 |
 |
Geschwind D. on PAPER: Dorval V. et al., 2006, Recommendation Only. 13 Feb 2006.
|
 |
 |
 |
 |
 |
Geschwind D. on PAPER: Khurana V. et al., 2006, Recommendation Only. 13 Feb 2006.
|
 |
 |
 |
 |
 |
Geschwind D. on PAPER: Rovelet-Lecrux A. et al., 2006, The role of copy number polymorphisms in human genetic variation has only recently been... 2 Jan 2006.
|
 |
 |
 |
 |
 |
Geschwind D. on PAPER: McKeith IG. et al., 2005, Recommendation Only. 2 Jan 2006.
|
 |
 |
 |
 |
 |
Geschwind D. on PAPER: Kuzu N. et al., 2005 Nov-Dec, Recommendation Only. 2 Jan 2006.
|
 |
 |
 |
 |
 |
Geschwind D. on PAPER: Berger Z. et al., 2006, Recommendation Only. 2 Jan 2006.
|
 |
 |
 |
 |
 |
Geschwind D. on PAPER: Sugino K. et al., 2006, This paper profiles individual neurons in the mouse brain using microrarrays. While the method... 2 Jan 2006.
|
 |
 |
 |
 |
 |
Geschwind D. on PAPER: Ringholz GM. et al., 2005, It is interesting to note that FTD occurs at a similar rate in ALS (15 percent), as ALS occurs... 30 Aug 2005.
|
 |
 |
 |
 |
 |
Geschwind D. on PAPER: Cai H. et al., 2005, It is now well-appreciated that so many of the models in mice that recapitulate the mutations... 30 Aug 2005.
|
 |
 |
 |
 |
 |
Geschwind D. on PAPER: Laferla FM. et al., 2006, Recommendation Only. 30 Aug 2005.
|
 |
 |
 |
 |
 |
Geschwind D. on PAPER: Callicott JH. et al., 2005, Recommendation Only. 18 Jun 2005.
|
 |
 |
 |
 |
 |
Geschwind D. on PAPER: Chen Q. et al., 2005, Recommendation Only. 18 Jun 2005.
|
 |
 |
 |
 |
 |
Geschwind D. on PAPER: Bertram L. et al., 2005, Recommendation Only. 18 Jun 2005.
|
 |
 |
 |
 |
 |
Geschwind D. on PAPER: Gatz M. et al., 2005, Recommendation Only. 23 Jan 2005.
|
 |
 |
 |
 |
 |
Geschwind D. on NEWS: Aiding and Abetting, Hyperactive CDK5 Gives Mouse Tangles, This paper is very relevant to our work and that of others. It begins to bring together the... 23 May 2003.
|
 |
 |
 |
 |
 |
 |
1 to 18 of 18 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Should the FDA be allowed to use data from overseas clinical trials? |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Absolutely, we are running out of viable subjects in the U.S. |
 |
 |
 |
 |
 |
 |
9 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Yes, so long as the data is reliable |
 |
 |
 |
 |
 |
 |
31 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the trials are not as rigorous |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the data should be repeated in the U.S. |
 |
 |
 |
 |
 |
 |
5 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the drug sponsors are just trying to cut corners |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Responses: 51 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Archived Polls |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |